Sun Pharmaceutical faces the heat as Q4 profit halves; Valia's role reduced
New Delhi, May 29 -- Sun Pharmaceutical Industries Ltd reported a 53% drop in quarterly profit after it took a Rs.1,085 crore one-time charge, following a corporate governance scandal that also led to founder Dilip Shanghvi's brother-in-law moving to a non-executive role....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.